United States Biotechnology & Medical Research

Beam Therapeutics Inc (BEAM)

Track

Track

Beam Therapeutics experienced significant insider selling over the past ninety days, totaling approximately 14.4 million dollars. Key executives, including the CEO and Chief Medical Officer, executed planned divestments alongside institutional sales. These activities occurred amidst a 21.7 percent stock price decline and following a recent earnings report that missed expectations.
Ticker: BEAM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Beam Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.18
Quantity 7,842 -6.0%
Value US$2,689,805
AMY SIMON Officer Officer
Transaction date
Proposed sale
Price
137.24
Quantity 88,870
Value US$3,717,581
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
309.97
Quantity 42,923 +45.2%
Value US$3,846,812
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
34.84
Quantity 1,900 -0.2%
Value US$66,203
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
34.26
Quantity 23,100 -2.2%
Value US$791,482
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
34.31
Quantity 25,000
Value US$857,685
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
35.91
Quantity 11,579 -1.1%
Value US$415,824
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
35.13
Quantity 13,421 -1.3%
Value US$471,528
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
35.49
Quantity 25,000
Value US$887,352
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
35.26
Quantity 251,488 -22.7%
Value US$8,867,467
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
35.12
Quantity 33,372 -2.9%
Value US$1,172,025
3.8
CAROLE HO Director Non-Executive Director
Transaction date
Proposed sale
Price
30.73
Quantity 87,784
Value US$2,698,015
CHRISTINE BELLON Officer Officer
Transaction date
Proposed sale
Price
21.90
Quantity 20,000
Value US$438,000
2.5
GIUSEPPE CIARAMELLA Officer Officer
Transaction date
Proposed sale
Price
21.90
Quantity 26,250
Value US$574,875
2.5
JOHN M. EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
21.90
Quantity 66,874
Value US$1,464,541
AMY SIMON Officer Officer
Transaction date
Proposed sale
Price
21.90
Quantity 20,000
Value US$438,000
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
24.58
Quantity 3,242 -6.0%
Value US$79,688
2.5
Ciaramella Giuseppe President Officer
Transaction date
Planned sale
Price
24.58
Quantity 11,810 -5.1%
Value US$290,290
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
24.58
Quantity 30,078 -2.8%
Value US$739,317
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.58
Quantity 6,700 -6.1%
Value US$164,686
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
24.58
Quantity 5,956 -5.1%
Value US$146,398
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
22.76
Quantity 25,000 -2.5%
Value US$569,085
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.76
Quantity 25,000
Value US$569,085
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
22.37
Quantity 25,000 -2.5%
Value US$559,230
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
22.37
Quantity 25,000
Value US$559,230
2.5
Ciaramella Giuseppe President Officer
Transaction date
Planned sale
Price
32.00
Quantity 35,000 -15.5%
Value US$1,120,042
2.5
GIUSEPPE CIARAMELLA Officer Officer
Transaction date
Proposed sale
Price
32.00
Quantity 35,000
Value US$1,120,042
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
29.00
Quantity 2,906 -0.3%
Value US$84,274
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
28.27
Quantity 22,094 -2.2%
Value US$624,672
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.36
Quantity 25,000
Value US$708,948
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
29.74
Quantity 8,667 -0.9%
Value US$257,781
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
29.19
Quantity 16,333 -1.6%
Value US$476,801
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
29.38
Quantity 25,000
Value US$734,582
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
34.00
Quantity 1,371 -1.4%
Value US$46,614
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
35.00
Quantity 6,198 -15.1%
Value US$216,933
CHRISTINE BELLON Officer Officer
Transaction date
Proposed sale
Price
34.00
Quantity 1,371
Value US$46,614
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
30.12
Quantity 3,034 -6.9%
Value US$91,384
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
35.40
Quantity 559 -0.6%
Value US$19,788
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
34.72
Quantity 15,959 -14.1%
Value US$554,068
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
33.62
Quantity 2,111 -1.8%
Value US$70,976
CHRISTINE BELLON Officer Officer
Transaction date
Proposed sale
Price
34.61
Quantity 18,629
Value US$644,831
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
27.10
Quantity 1,254 -1.1%
Value US$33,983
2.2
Emany Sravan Kumar Chief Financial Officer Officer
Transaction date
Planned sale
Price
27.10
Quantity 6,294 -7.9%
Value US$170,567
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
26.68
Quantity 459 -97.0%
Value US$12,246
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
24.63
Quantity 25,000 -2.5%
Value US$615,668
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
24.63
Quantity 25,000
Value US$615,668
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
24.53
Quantity 373 -0.3%
Value US$9,150
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
24.53
Quantity 467 -1.0%
Value US$11,456
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
24.51
Quantity 25,000 -2.5%
Value US$612,655
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
24.51
Quantity 25,000
Value US$612,655
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
20.50
Quantity 48,374 -2.3%
Value US$991,667
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.12
Quantity 876 -1.3%
Value US$17,625
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
16.94
Quantity 374 -0.6%
Value US$6,336
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
17.73
Quantity 20,997 -24.2%
Value US$372,294
AMY SIMON Officer Officer
Transaction date
Proposed sale
Price
17.73
Quantity 20,997
Value US$372,294
2.5
Ciaramella Giuseppe President Officer
Transaction date
Planned sale
Price
18.35
Quantity 7,434 -3.8%
Value US$136,418
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
18.35
Quantity 3,015 -6.3%
Value US$55,330
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.35
Quantity 5,674 -4.6%
Value US$104,122
Simon Amy Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.35
Quantity 9,566 -9.9%
Value US$175,542
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
18.35
Quantity 30,663 -3.0%
Value US$562,684
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
35.00
Quantity 6,287 -14.3%
Value US$220,045
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
34.00
Quantity 10,000 -8.9%
Value US$340,000
CHRISTINE BELLON Officer Officer
Transaction date
Proposed sale
Price
34.00
Quantity 10,000
Value US$340,000
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
27.28
Quantity 200 -0.0%
Value US$5,456
2.5
Evans John M. CEO Executive Director
Transaction date
Planned sale
Price
26.75
Quantity 29,800 -3.2%
Value US$797,028
2.5
JOHN M EVANS Officer; Director Executive Director
Transaction date
Proposed sale
Price
26.75
Quantity 30,000
Value US$802,482
Bellon Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
24.68
Quantity 1,241 -1.2%
Value US$30,628
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
24.68
Quantity 1,117 -2.5%
Value US$27,568
BETHANY J. CAVANAGH Officer Officer
Transaction date
Proposed sale
Price
25.27
Quantity 9,500
Value US$240,065
CHRISTINE BELLON Officer Officer
Transaction date
Proposed sale
Price
25.27
Quantity 4,167
Value US$105,300
2.5
Ciaramella Giuseppe President Officer
Transaction date
Planned sale
Price
26.36
Quantity 51,110 -31.9%
Value US$1,347,050
2.5
Ciaramella Giuseppe President Officer
Transaction date
Planned sale
Price
26.27
Quantity 51,110 -24.2%
Value US$1,342,752
2.5
Giuseppe Ciaramella Officer Officer
Transaction date
Proposed sale
Price
24.65
Quantity 102,220
Value US$2,519,723
2.5
Burrell Terry-Ann Officer Officer
Transaction date
Proposed sale
Price
23.00
Quantity 185,565
Value US$4,267,995
Cavanagh Bethany J SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
23.48
Quantity 289 -0.6%
Value US$6,785
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
7,842 -6.0%
20.18
US$2,689,805 		7,842 -6.0% 20.18 US$2,689,805
2026-07-27 2026-07-27 PrS Proposed sale
AMY SIMON

Officer

Officer
88,870
137.24
US$3,717,581 		88,870 137.24 US$3,717,581
2026-07-02 2026-06-30 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
42,923 +45.2%
309.97
US$3,846,812 		42,923 +45.2% 309.97 US$3,846,812
2026-07-01 2026-06-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
1,900 -0.2%
34.84
US$66,203 		1,900 -0.2% 34.84 US$66,203
2026-07-01 2026-06-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
23,100 -2.2%
34.26
US$791,482 		23,100 -2.2% 34.26 US$791,482
2026-06-30 2026-06-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
34.31
US$857,685 		25,000 34.31 US$857,685
2026-07-01 2026-06-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
11,579 -1.1%
35.91
US$415,824 		11,579 -1.1% 35.91 US$415,824
2026-07-01 2026-06-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
13,421 -1.3%
35.13
US$471,528 		13,421 -1.3% 35.13 US$471,528
2026-06-29 2026-06-29 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
35.49
US$887,352 		25,000 35.49 US$887,352
2026-06-29 2026-06-26 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
251,488 -22.7%
35.26
US$8,867,467 		251,488 -22.7% 35.26 US$8,867,467
2026-06-29 2026-06-25 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
33,372 -2.9%
35.12
US$1,172,025 		33,372 -2.9% 35.12 US$1,172,025
2026-04-14 2026-04-14 PrS Proposed sale
3.8
CAROLE HO

Director

Non-Executive Director
87,784
30.73
US$2,698,015 		87,784 30.73 US$2,698,015
2026-03-31 2026-04-02 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
20,000
21.90
US$438,000 		20,000 21.90 US$438,000
2026-03-31 2026-04-02 PrS Proposed sale
2.5
GIUSEPPE CIARAMELLA

Officer

Officer
26,250
21.90
US$574,875 		26,250 21.90 US$574,875
2026-03-31 2026-04-02 PrS Proposed sale
2.5
JOHN M. EVANS

Officer; Director

Executive Director
66,874
21.90
US$1,464,541 		66,874 21.90 US$1,464,541
2026-03-31 2026-04-02 PrS Proposed sale
AMY SIMON

Officer

Officer
20,000
21.90
US$438,000 		20,000 21.90 US$438,000
2026-04-06 2026-04-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,242 -6.0%
24.58
US$79,688 		3,242 -6.0% 24.58 US$79,688
2026-04-06 2026-04-01 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
11,810 -5.1%
24.58
US$290,290 		11,810 -5.1% 24.58 US$290,290
2026-04-06 2026-04-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
30,078 -2.8%
24.58
US$739,317 		30,078 -2.8% 24.58 US$739,317
2026-04-06 2026-04-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
6,700 -6.1%
24.58
US$164,686 		6,700 -6.1% 24.58 US$164,686
2026-04-06 2026-04-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
5,956 -5.1%
24.58
US$146,398 		5,956 -5.1% 24.58 US$146,398
2026-04-01 2026-03-31 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
22.76
US$569,085 		25,000 -2.5% 22.76 US$569,085
2026-03-31 2026-03-31 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
22.76
US$569,085 		25,000 22.76 US$569,085
2026-04-01 2026-03-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
22.37
US$559,230 		25,000 -2.5% 22.37 US$559,230
2026-03-30 2026-03-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
22.37
US$559,230 		25,000 22.37 US$559,230
2026-02-26 2026-02-24 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
35,000 -15.5%
32.00
US$1,120,042 		35,000 -15.5% 32.00 US$1,120,042
2026-02-24 2026-02-24 PrS Proposed sale
2.5
GIUSEPPE CIARAMELLA

Officer

Officer
35,000
32.00
US$1,120,042 		35,000 32.00 US$1,120,042
2026-02-02 2026-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
2,906 -0.3%
29.00
US$84,274 		2,906 -0.3% 29.00 US$84,274
2026-02-02 2026-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
22,094 -2.2%
28.27
US$624,672 		22,094 -2.2% 28.27 US$624,672
2026-01-30 2026-01-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
28.36
US$708,948 		25,000 28.36 US$708,948
2026-02-02 2026-01-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
8,667 -0.9%
29.74
US$257,781 		8,667 -0.9% 29.74 US$257,781
2026-02-02 2026-01-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
16,333 -1.6%
29.19
US$476,801 		16,333 -1.6% 29.19 US$476,801
2026-01-29 2026-01-29 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
29.38
US$734,582 		25,000 29.38 US$734,582
2026-01-26 2026-01-22 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,371 -1.4%
34.00
US$46,614 		1,371 -1.4% 34.00 US$46,614
2026-01-26 2026-01-22 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
6,198 -15.1%
35.00
US$216,933 		6,198 -15.1% 35.00 US$216,933
2026-01-22 2026-01-22 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
1,371
34.00
US$46,614 		1,371 34.00 US$46,614
2026-01-21 2026-01-20 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,034 -6.9%
30.12
US$91,384 		3,034 -6.9% 30.12 US$91,384
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
559 -0.6%
35.40
US$19,788 		559 -0.6% 35.40 US$19,788
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
15,959 -14.1%
34.72
US$554,068 		15,959 -14.1% 34.72 US$554,068
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
2,111 -1.8%
33.62
US$70,976 		2,111 -1.8% 33.62 US$70,976
2026-01-15 2026-01-15 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
18,629
34.61
US$644,831 		18,629 34.61 US$644,831
2026-01-05 2025-12-31 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,254 -1.1%
27.10
US$33,983 		1,254 -1.1% 27.10 US$33,983
2026-01-05 2025-12-31 PlS Planned sale
2.2
Emany Sravan Kumar

Chief Financial Officer

Officer
6,294 -7.9%
27.10
US$170,567 		6,294 -7.9% 27.10 US$170,567
2025-10-29 2025-10-27 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
459 -97.0%
26.68
US$12,246 		459 -97.0% 26.68 US$12,246
2025-10-03 2025-10-02 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
24.63
US$615,668 		25,000 -2.5% 24.63 US$615,668
2025-10-02 2025-10-02 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
24.63
US$615,668 		25,000 24.63 US$615,668
2025-10-03 2025-10-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
373 -0.3%
24.53
US$9,150 		373 -0.3% 24.53 US$9,150
2025-10-03 2025-10-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
467 -1.0%
24.53
US$11,456 		467 -1.0% 24.53 US$11,456
2025-10-03 2025-10-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
24.51
US$612,655 		25,000 -2.5% 24.51 US$612,655
2025-10-01 2025-10-01 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
24.51
US$612,655 		25,000 24.51 US$612,655
2025-08-01 2025-07-30 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
48,374 -2.3%
20.50
US$991,667 		48,374 -2.3% 20.50 US$991,667
2025-07-03 2025-07-03 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
876 -1.3%
20.12
US$17,625 		876 -1.3% 20.12 US$17,625
2025-07-03 2025-07-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
374 -0.6%
16.94
US$6,336 		374 -0.6% 16.94 US$6,336
2025-04-03 2025-04-02 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
20,997 -24.2%
17.73
US$372,294 		20,997 -24.2% 17.73 US$372,294
2025-04-02 2025-04-02 PrS Proposed sale
AMY SIMON

Officer

Officer
20,997
17.73
US$372,294 		20,997 17.73 US$372,294
2025-04-03 2025-04-01 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
7,434 -3.8%
18.35
US$136,418 		7,434 -3.8% 18.35 US$136,418
2025-04-03 2025-04-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,015 -6.3%
18.35
US$55,330 		3,015 -6.3% 18.35 US$55,330
2025-04-03 2025-04-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
5,674 -4.6%
18.35
US$104,122 		5,674 -4.6% 18.35 US$104,122
2025-04-03 2025-04-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
9,566 -9.9%
18.35
US$175,542 		9,566 -9.9% 18.35 US$175,542
2025-04-03 2025-04-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
30,663 -3.0%
18.35
US$562,684 		30,663 -3.0% 18.35 US$562,684
2025-02-20 2025-02-18 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
6,287 -14.3%
35.00
US$220,045 		6,287 -14.3% 35.00 US$220,045
2025-02-19 2025-02-14 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
10,000 -8.9%
34.00
US$340,000 		10,000 -8.9% 34.00 US$340,000
2025-02-14 2025-02-14 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
10,000
34.00
US$340,000 		10,000 34.00 US$340,000
2025-02-03 2025-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
200 -0.0%
27.28
US$5,456 		200 -0.0% 27.28 US$5,456
2025-02-03 2025-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
29,800 -3.2%
26.75
US$797,028 		29,800 -3.2% 26.75 US$797,028
2025-01-30 2025-01-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
30,000
26.75
US$802,482 		30,000 26.75 US$802,482
2025-01-06 2025-01-02 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,241 -1.2%
24.68
US$30,628 		1,241 -1.2% 24.68 US$30,628
2025-01-06 2025-01-02 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
1,117 -2.5%
24.68
US$27,568 		1,117 -2.5% 24.68 US$27,568
2024-12-30 2024-12-31 PrS Proposed sale
BETHANY J. CAVANAGH

Officer

Officer
9,500
25.27
US$240,065 		9,500 25.27 US$240,065
2024-12-30 2024-12-31 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
4,167
25.27
US$105,300 		4,167 25.27 US$105,300
2024-11-08 2024-11-06 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
51,110 -31.9%
26.36
US$1,347,050 		51,110 -31.9% 26.36 US$1,347,050
2024-10-16 2024-10-14 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
51,110 -24.2%
26.27
US$1,342,752 		51,110 -24.2% 26.27 US$1,342,752
2024-10-15 2024-10-14 PrS Proposed sale
2.5
Giuseppe Ciaramella

Officer

Officer
102,220
24.65
US$2,519,723 		102,220 24.65 US$2,519,723
2024-10-07 2024-10-07 PrS Proposed sale
2.5
Burrell Terry-Ann

Officer

Officer
185,565
23.00
US$4,267,995 		185,565 23.00 US$4,267,995
2024-10-02 2024-10-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
289 -0.6%
23.48
US$6,785 		289 -0.6% 23.48 US$6,785
Explore more

More insider trading research around Beam Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America